Cargando…

Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer

OBJECTIVE: By identifying the clinicopathological characteristics and prognostic influences of patients with triple-positive breast cancer (TPBC) at Xijing Hospital in China compared with those in the United States, this study aims to construct a nomogram model to forecast the overall survival rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Anqi, Xiao, Jingjing, Dong, Bingyao, Yuan, Shifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931069/
https://www.ncbi.nlm.nih.gov/pubmed/36816930
http://dx.doi.org/10.3389/fonc.2023.1071076
_version_ 1784889166169899008
author Geng, Anqi
Xiao, Jingjing
Dong, Bingyao
Yuan, Shifang
author_facet Geng, Anqi
Xiao, Jingjing
Dong, Bingyao
Yuan, Shifang
author_sort Geng, Anqi
collection PubMed
description OBJECTIVE: By identifying the clinicopathological characteristics and prognostic influences of patients with triple-positive breast cancer (TPBC) at Xijing Hospital in China compared with those in the United States, this study aims to construct a nomogram model to forecast the overall survival rate (OS) of TPBC patients. METHOD: The Surveillance, Epidemiology, and End Results (SEER) database was used to screen 5769 patients as the training cohort, and 191 patients from Xijing Hospital were used as the validation cohort. Cox risk-proportional model was applied to select variables and the nomogram model was constructed based on the training cohort. The performance of the model was evaluated by calculating the C-index and generating calibration plots in the training and validation cohorts. RESULTS: Cox multifactorial analysis showed that age, chemotherapy, radiotherapy, M-stage, T-stage, N-stage, and the mode of surgery were all independent risk factors for the prognosis of TPBC patients (all P<0.05). With this premise, the nomogram model was constructed and evaluated. The C-index value of the nomogram model was 0.830 in the training group and 0.914 in the validation group. Moreover, both the calibration and ROC curves for the proposed model exhibited reliable performance, and the clinical decision curve analysis showed that the proposed model can bring clinical benefits. CONCLUSIONS: The constructed nomogram can accurately predict individual survival probabilities and may serve as a clinical decision support tool for clinicians to optimize treatment in individuals.
format Online
Article
Text
id pubmed-9931069
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99310692023-02-16 Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer Geng, Anqi Xiao, Jingjing Dong, Bingyao Yuan, Shifang Front Oncol Oncology OBJECTIVE: By identifying the clinicopathological characteristics and prognostic influences of patients with triple-positive breast cancer (TPBC) at Xijing Hospital in China compared with those in the United States, this study aims to construct a nomogram model to forecast the overall survival rate (OS) of TPBC patients. METHOD: The Surveillance, Epidemiology, and End Results (SEER) database was used to screen 5769 patients as the training cohort, and 191 patients from Xijing Hospital were used as the validation cohort. Cox risk-proportional model was applied to select variables and the nomogram model was constructed based on the training cohort. The performance of the model was evaluated by calculating the C-index and generating calibration plots in the training and validation cohorts. RESULTS: Cox multifactorial analysis showed that age, chemotherapy, radiotherapy, M-stage, T-stage, N-stage, and the mode of surgery were all independent risk factors for the prognosis of TPBC patients (all P<0.05). With this premise, the nomogram model was constructed and evaluated. The C-index value of the nomogram model was 0.830 in the training group and 0.914 in the validation group. Moreover, both the calibration and ROC curves for the proposed model exhibited reliable performance, and the clinical decision curve analysis showed that the proposed model can bring clinical benefits. CONCLUSIONS: The constructed nomogram can accurately predict individual survival probabilities and may serve as a clinical decision support tool for clinicians to optimize treatment in individuals. Frontiers Media S.A. 2023-02-01 /pmc/articles/PMC9931069/ /pubmed/36816930 http://dx.doi.org/10.3389/fonc.2023.1071076 Text en Copyright © 2023 Geng, Xiao, Dong and Yuan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Geng, Anqi
Xiao, Jingjing
Dong, Bingyao
Yuan, Shifang
Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
title Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
title_full Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
title_fullStr Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
title_full_unstemmed Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
title_short Analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
title_sort analysis of prognostic factors and construction of prognostic models for triple-positive breast cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931069/
https://www.ncbi.nlm.nih.gov/pubmed/36816930
http://dx.doi.org/10.3389/fonc.2023.1071076
work_keys_str_mv AT genganqi analysisofprognosticfactorsandconstructionofprognosticmodelsfortriplepositivebreastcancer
AT xiaojingjing analysisofprognosticfactorsandconstructionofprognosticmodelsfortriplepositivebreastcancer
AT dongbingyao analysisofprognosticfactorsandconstructionofprognosticmodelsfortriplepositivebreastcancer
AT yuanshifang analysisofprognosticfactorsandconstructionofprognosticmodelsfortriplepositivebreastcancer